Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer Multicenter prospective ...
aChronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland bWelfare and Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results